SCHEMBL2805867

SCHEMBL2805867

O=C(O)CCN(CCN(CCC(=O)O)CC(=O)O)CC(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.74
PMP22 Q01453 3/20 0.74
TDP1 Q9NUW8 2/20 0.74
BLM P54132 2/20 0.74
TSHR P16473 2/20 0.74
KDM4E B2RXH2 2/20 0.74
CHRM2 P08172 1/20 0.74
ADRA2A P08913 1/20 0.74
ALOX15 P16050 1/20 0.74
DRD1 P21728 1/20 0.74
SLC6A2 P23975 1/20 0.74
SLC6A4 P31645 1/20 0.74
CYP2C19 P33261 1/20 0.74
ADRA1A P35348 1/20 0.74
DRD3 P35462 1/20 0.74
SLC6A3 Q01959 1/20 0.74
HRH3 Q9Y5N1 1/20 0.74
EYA2 O00167 1/20 0.68
APP P05067 1/20 0.68
ACE P12821 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10338095 1.00 LMNA (0.74) LMNAPMP22TDP1BLMTSHR
Water SCHEMBL4058718 0.97 LMNA (0.70) LMNAPMP22TDP1BLMTSHR
SCHEMBL8663727 0.97 TDP1 (0.79) LMNAPMP22TDP1BLMTSHR
SCHEMBL29223102 0.97 LMNA (0.70) LMNAPMP22TDP1BLMTSHR
SCHEMBL13198811 0.97 TDP1 (0.79) LMNAPMP22TDP1BLMTSHR
SCHEMBL562831 0.97 LMNA (0.68) LMNAPMP22TDP1BLMTSHR
SCHEMBL11636902 0.92 TDP1 (0.74) LMNAPMP22TDP1BLMTSHR
Nitrilotriacetic Acid SCHEMBL9066282 0.92 TDP1 (0.65) LMNAPMP22TDP1BLMTSHR
SCHEMBL21412890 0.92 TDP1 (0.74) LMNAPMP22TDP1BLMTSHR
SCHEMBL14315915 0.92 TDP1 (0.74) LMNAPMP22TDP1BLMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116655737-A XO inhibitory peptides and uses thereof 中国海洋大学 2023-08-29 CN claimed
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US claimed
EP-1403339-B1 Black ink for inkjet recording FUJIFILM CORP (JP) 2013-03-06 EP claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
EP-1434735-B1 STABILIZED HYDROXYLAMINE SOLUTIONS BASF AG (DE) 2006-10-25 EP claimed
CN-119219734-A XO inhibitory peptide GDEY and application thereof 中国海洋大学 2024-12-31 CN disclosed
CN-116655737-B XO inhibitory peptides and uses thereof 中国海洋大学 2024-12-31 CN disclosed
CN-119143837-A XO inhibitory peptide AGDY and application thereof 中国海洋大学 2024-12-17 CN disclosed
EP-4323615-A1 DYNAMIC GLASS ELEMENT USING REVERSIBLE METAL ELECTRODEPOSITION ELECTROLYTES WITH TUNABLE PH WITH HIGH OPACITY AND EXCELLENT RESTING STABILITY AND ELECTROLYTES USEFUL THEREFORE Board of Regents of the Nevada System of Higher Education, on Behalf of the University of Nevada, Reno (US) 2024-02-21 EP disclosed
CN-114908027-B Pantothenic acid production related strain, construction method and application thereof 天津科技大学 2023-12-26 CN disclosed
US-20230285391-A1 STABLE LIQUID COMPOSITIONS OF POSACONAZOLE INVENGENE PRIVATE LIMITED (IN) 2023-09-14 US disclosed
CN-116655737-A XO inhibitory peptides and uses thereof 中国海洋大学 2023-08-29 CN disclosed
US-20040070654-A1 Black ink for inkjet recording FUJI PHOTO FILM CO., LTD. 2004-04-15 US disclosed
EP-1403339-A1 Black ink for inkjet recording FUJI PHOTO FILM CO., LTD. (JP) 2004-03-31 EP disclosed
EP-0713139-B1 Novel, iron complex, process for producing the same, photographic processing composition and processing process using the same FUJI PHOTO FILM CO LTD (JP) 1998-06-03 EP disclosed
US-5547817-A BLEACHING AGENTS FUJI PHOTO FILM CO., LTD. (JP) 1996-08-20 US disclosed
EP-0713139-A1 Novel, iron complex, process for producing the same, photographic processing composition and processing process using the same FUJI PHOTO FILM CO., LTD. (JP) 1996-05-22 EP disclosed
US-5201998-A Process for sizing paper with anionic hydrophobic sizing agents and cationic retention aids CIBA-GEIGY CORPORATION (US) 1993-04-13 US disclosed
US-4247620-A TETRAARYL PHOSPHONIUM, AMMONIUM OR ARSONIUM METAL POLYCARBOXYLATES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1981-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 LMNA 1561/4885PMP22 1384/4885TDP1 3475/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA LMNA 833/4885PMP22 4029/4885TDP1 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.